Levetiracetam and Psoriasis - a phase IV clinical study of FDA data
Summary:
Psoriasis is reported as a side effect among people who take Levetiracetam (levetiracetam), especially for people who are male, 60+ old, have been taking the drug for 6 - 12 months also take Otezla, and have High blood pressure.
The phase IV clinical study analyzes which people have Psoriasis when taking Levetiracetam. It is created by eHealthMe based on reports of 74,747 people who have side effects when taking Levetiracetam from the FDA, and is updated regularly.
What is Levetiracetam?
Levetiracetam has active ingredients of levetiracetam. It is often used in epilepsy. eHealthMe is studying from 75,292 Levetiracetam users. Check the latest studies of Levetiracetam.
What is Psoriasis?
Psoriasis (immune-mediated disease that affects the skin) is found to be associated with 1,474 drugs and 1,695 conditions by eHealthMe. Check the latest studies of Psoriasis.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
74,747 people reported to have side effects when taking Levetiracetam.
Among them, 88 people (0.12%) have Psoriasis.

Among these 88 people:
How long have people been on Levetiracetam when they have Psoriasis? *
- < 1 month: 0.0 %
- 1 - 6 months: 50 %
- 6 - 12 months: 50 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Psoriasis when taking Levetiracetam? *
- female: 38.55 %
- male: 61.45 %
What is the age of people who have Psoriasis when taking Levetiracetam? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 1.92 %
- 30-39: 13.46 %
- 40-49: 17.31 %
- 50-59: 23.08 %
- 60+: 44.23 %
What are other drugs people take besides Levetiracetam? *
- Otezla: 27 people, 30.68%
- Metformin: 17 people, 19.32%
- Amlodipine: 13 people, 14.77%
- Ondansetron: 11 people, 12.50%
- Humira: 11 people, 12.50%
- Cosentyx: 9 people, 10.23%
- Tamsulosin: 9 people, 10.23%
- Pantoprazole: 8 people, 9.09%
- Hydroxyzine: 8 people, 9.09%
- Oxycodone: 8 people, 9.09%
What are other side effects people have besides Psoriasis? *
- Dizziness: 15 people, 17.05%
- Itching: 12 people, 13.64%
- Fatigue (feeling of tiredness): 10 people, 11.36%
- Nausea (feeling of having an urge to vomit): 9 people, 10.23%
- Pain: 9 people, 10.23%
- Drug Ineffective: 9 people, 10.23%
- Pain In Extremity: 9 people, 10.23%
- Influenza Like Illness: 8 people, 9.09%
- Hepatitis (inflammation of the liver): 8 people, 9.09%
- Eye Oedema (swelling or thickening of the macula, the area of the retina responsible for central vision): 8 people, 9.09%
What are the existing conditions these people have? *
- Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 9 people, 10.23%
- High Blood Pressure: 9 people, 10.23%
- Malignant Melanoma (skin cancer rises from melancytes): 8 people, 9.09%
- Diabetes: 7 people, 7.95%
- High Blood Cholesterol: 7 people, 7.95%
- Prostate Cancer: 5 people, 5.68%
- Depression: 4 people, 4.55%
- Insomnia (sleeplessness): 3 people, 3.41%
- Constipation: 3 people, 3.41%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 3.41%
* Approximation only. Some reports may have incomplete information.
Do you take Levetiracetam and have Psoriasis?
- Check whether Psoriasis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Levetiracetam:
- Levetiracetam (75,292 reports)
Psoriasis treatments and more:
- Psoriasis (508,164 reports)
How severe was Psoriasis and when was it recovered:
Expand to all the drugs that have ingredients of levetiracetam:
- Psoriasis and drugs with ingredients of levetiracetam (196 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Levetiracetam:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Psoriasis:
- Psoriasis (1,474 drugs)
Browse all the conditions that are associated with Psoriasis:
- Psoriasis (1,695 conditions)
Related publications that referenced our studies
- Mohagheghi MA, Omranipur R, Ensani F, Ghannadan A, Shahriaran S, Samiee F, Sedighi Z, "A Case of Advanced Unicentric Retroperitoneal Castleman's Disease, Associated With Psoriasis", Acta Medica Iranica, 2017 May .
- Schattner A, Al-Bewerat A, "Levetiracetam (Keppra), urinary retention and literature search", A fatty cause of renal failure; what is your diagnosis?, 2016 Oct .
- Chiriac A, Brzezinski P, Stolnicu S, Podoleanu C, Moldovan C, Molnar C, Taranu T, "Eosinophilia–A rare possible adverse reaction during anti-tumor necrosis factor-alpha therapy for psoriasis", Journal of Dermatological Treatment, 2016 Mar .
- Spengler DC, Montouris GD, Hohler AD, "Levetiracetam as a possible contributor to acute kidney injury", Clinical therapeutics, 2014 Aug .
- Almeida DM, Jean MR, Chystsiakova A, Monahan E, Oliveira SB, Monteiro IM, "Levetiracetam-associated acute pancreatitis in an adolescent with autism: a case report", Pancreas, 2013 Jan .
- Malisiewicz B, Murer C, Schmid JP, French LE, Schmid-Grendelmeier P, Navarini AA, "Eosinophilia during psoriasis treatment with TNF antagonists", Dermatology, 2013 Jan .
- Mohagheghi MA, Omranipur R, Ensani F, Ghannadan A, Shahriaran S, Samiee F, Sedighi Z, "A Case of Advanced Unicentric Retroperitoneal Castleman's Disease, Associated With Psoriasis", Acta Medica Iranica, 2017 May .
- Schattner A, Al-Bewerat A, "Levetiracetam (Keppra), urinary retention and literature search", A fatty cause of renal failure; what is your diagnosis?, 2016 Oct .
- Chiriac A, Brzezinski P, Stolnicu S, Podoleanu C, Moldovan C, Molnar C, Taranu T, "Eosinophilia–A rare possible adverse reaction during anti-tumor necrosis factor-alpha therapy for psoriasis", Journal of Dermatological Treatment, 2016 Mar .
- Spengler DC, Montouris GD, Hohler AD, "Levetiracetam as a possible contributor to acute kidney injury", Clinical therapeutics, 2014 Aug .
- Almeida DM, Jean MR, Chystsiakova A, Monahan E, Oliveira SB, Monteiro IM, "Levetiracetam-associated acute pancreatitis in an adolescent with autism: a case report", Pancreas, 2013 Jan .
- Malisiewicz B, Murer C, Schmid JP, French LE, Schmid-Grendelmeier P, Navarini AA, "Eosinophilia during psoriasis treatment with TNF antagonists", Dermatology, 2013 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on levetiracetam (the active ingredients of Levetiracetam) and Levetiracetam (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Peppermint and Proair Hfa - a second ago
- Alprazolam and Fungal Infection for Men aged 30-39 - 45 seconds ago
- Psoriatic Arthropathy and Pulmonary Mass - 48 seconds ago
- Could Dotarem cause General Physical Health Deterioration? - a minute ago
- Could Breo Ellipta cause Confusion? - a minute ago
- Arava vs. Medrol, side effect and effectiveness comparison - 2 minutes ago
- Drug interactions of Flexeril and Januvia - 2 minutes ago
- Could Hydrochlorothiazide cause Helicobacter Infection? - 2 minutes ago
- Could Simponi Aria cause Peripheral Swelling? - 3 minutes ago
- Could Plaquenil cause Paraesthesia? - 3 minutes ago